You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Inflammatory Targets in Diabetic Nephropathy
Contributor:
Donate-Correa, Javier;
Luis-Rodríguez, Desirée;
Martín-Núñez, Ernesto;
Tagua, Víctor G.;
Hernández-Carballo, Carolina;
Ferri, Carla;
Rodríguez-Rodríguez, Ana Elena;
Mora-Fernández, Carmen;
Navarro-González, Juan F.
Published:
MDPI AG, 2020
Published in:
Journal of Clinical Medicine, 9 (2020) 2, Seite 458
Language:
English
DOI:
10.3390/jcm9020458
ISSN:
2077-0383
Origination:
Footnote:
Description:
One of the most frequent complications in patients with diabetes mellitus is diabetic nephropathy (DN). At present, it constitutes the first cause of end stage renal disease, and the main cause of cardiovascular morbidity and mortality in these patients. Therefore, it is clear that new strategies are required to delay the development and the progression of this pathology. This new approach should look beyond the control of traditional risk factors such as hyperglycemia and hypertension. Currently, inflammation has been recognized as one of the underlying processes involved in the development and progression of kidney disease in the diabetic population. Understanding the cascade of signals and mechanisms that trigger this maladaptive immune response, which eventually leads to the development of DN, is crucial. This knowledge will allow the identification of new targets and facilitate the design of innovative therapeutic strategies. In this review, we focus on the pathogenesis of proinflammatory molecules and mechanisms related to the development and progression of DN, and discuss the potential utility of new strategies based on agents that target inflammation.